SRZN
Surrozen Inc
NASDAQ: SRZN · HEALTHCARE · BIOTECHNOLOGY
$31.56
+1.87% today
Updated 2026-04-29
Market cap
$371.23M
P/E ratio
—
P/S ratio
106.77x
EPS (TTM)
$-32.37
Dividend yield
—
52W range
$6 – $34
Volume
0.1M
Surrozen Inc (SRZN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,394.00%
ROE
-62.80%
ROA
-35.70%
Debt/equity
-0.30x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-24.36M | — | — | — |
| 2020 | $0.00 | $-32.63M | — | — | — |
| 2021 | $0.00 | $-52.51M | — | — | — |
| 2022 | $12.50M | $-27.67M | 100.00% | -354.71% | -221.35% |
| 2023 | $12.50M | $-43.04M | -217.84% | -366.24% | -344.34% |
| 2024 | $10.65M | $-63.56M | 100.00% | -239.69% | -596.56% |
| 2025 | $3.48M | $-242.03M | 84.56% | -1,210.58% | -6,960.77% |